1.
Spontaneous bacterial peritonitis: recent guidelines and beyond
by Wiest, R
Gut, 2012-02, Vol.61 (2), p.297-69
2.
Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites
by Krag, A
Gut, 2010-01, Vol.59 (1), p.105-110
3.
Systematic review with meta‐analysis: the effects of rifaximin in hepatic encephalopathy
by Kimer, N.
Alimentary pharmacology & therapeutics, 2014-07, Vol.40 (2), p.123-132
4.
Editorial: in vino veritas – transient elastography for staging liver fibrosis in alcoholic liver disease
by Thiele, M.
Alimentary pharmacology & therapeutics, 2016-05, Vol.43 (9), p.1014-1015
5.
Novel serological neo‐epitope markers of extracellular matrix proteins for the detection of portal hypertension
by Leeming, D. J.
Alimentary pharmacology & therapeutics, 2013-11, Vol.38 (9), p.1086-1096
6.
Meta-analysis: the safety and efficacy of vaptans (tolvaptan, satavaptan and lixivaptan) in cirrhosis with ascites or hyponatraemia
by Dahl, E.
Alimentary pharmacology & therapeutics, 2012-10, Vol.36 (7), p.619-626
7.
Meta-analysis: banding ligation and medical interventions for the prevention of rebleeding from oesophageal varices
by Thiele, M.
Alimentary pharmacology & therapeutics, 2012-05, Vol.35 (10), p.1155-1165
8.
Fibrosis is not just fibrosis – basement membrane modelling and collagen metabolism differs between hepatitis B‐ and C‐induced injury
by Nielsen, M. J.
Alimentary pharmacology & therapeutics, 2016-12, Vol.44 (11-12), p.1242-1252
9.
Review article: the efficacy of biomarkers in chronic fibroproliferative diseases – early diagnosis and prognosis, with liver fibrosis as an exemplar
by Karsdal, M. A.
Alimentary pharmacology & therapeutics, 2014-08, Vol.40 (3), p.233-249
10.
Meta‐analysis: isosorbide‐mononitrate alone or with either beta‐blockers or endoscopic therapy for the management of oesophageal varices
by Gluud, L. L.
Alimentary pharmacology & therapeutics, 2010-10, Vol.32 (7), p.859-871
11.
Letter: the effects of rifaximin in hepatic encephalopathy – authors' reply
by Kimer, N.
Alimentary pharmacology & therapeutics, 2014-10, Vol.40 (7), p.858-859
12.
Letter: vaptans for the treatment of hyponatraemia and ascites in patients with cirrhosis - authors' reply
by Gluud, L. L.
Alimentary pharmacology & therapeutics, 2012-12, Vol.36 (11-12), p.1104-1104
13.
Serum Neutrophil Gelatinase-Associated Lipocalin – A Sensitive Novel Marker of Renal Impairment in Liver Cirrhosis?
by Gerbes, A.L
Digestion, 2011-07, Vol.84 (1), p.82-83
14.
Endoscopic variceal ligation alone or with pharmacological therapy for recurrent variceal bleeding: the importance of intention‐to‐treat analyses
by Krag, A.
Alimentary pharmacology & therapeutics, 2010-01, Vol.31 (2), p.341-343
15.
Prescribing of acid suppressive therapy: interactions between hospital and primary care
by KRAG, A.
Alimentary pharmacology & therapeutics, 2006-06, Vol.23 (12), p.1713-1718
16.
The impact of gender on the long-term morbidity and mortality of patients with type 2 diabetes receiving structured personal care: a 13 year follow-up study
by Krag, Marlene Ø
Diabetologia, 2015-11-26, Vol.59 (2), p.275-285
17.
Meta-analysis: isosorbide-mononitrate alone or with either beta-blockers or endoscopic therapy for the management of oesophageal varices: Meta-analysis: isosorbide-mononitrate for...
by Gluud, L. L.
Alimentary pharmacology & therapeutics, 2010-10, Vol.32 (7), p.859-871
18.
Hyponatraemia during terlipressin therapy
by Krag, Aleksander
Gut, 2010-03, Vol.59 (3), p.417-418
19.
Endoscopic variceal ligation alone or with pharmacological therapy for recurrent variceal bleeding: the importance of intention-to-treat analyses: LETTERS TO THE EDITORS
by Krag, A.
Alimentary pharmacology & therapeutics, 2010-01, Vol.31 (2), p.341-343
20.
Systematic Review with Meta-Analyses of Randomized Trials on Isosorbide-Mononitrate Alone or With Beta-Blockers or Endoscopic Therapy for Esophageal Varices
by Gluud, Lise Lotte
Alimentary pharmacology & therapeutics, 2010-08-15, Vol.32 (7), p.859
